The third-quarter earnings season has started with a bang, spreading optimism among investors.
Author archives: Sweta Jaiswal, FRM
Can Biotech ETFs Gain From Positive Booster Update?
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.
Will ETFs Gain From Upbeat US Homebuilder Confidence in October?
The U.S. housing sector scenario seems to improve with strength in housing demand amid persistent supply-chain constraints that can impact affordability.
Will China ETFs Suffer From Weak Economic Data Releases?
Surging raw material prices, power shortages, a slowdown in the property sector and COVID-related constraints are likely to have impeded third-quarter economic growth.
Will ETFs Suffer as US Consumer Sentiment Falls in October?
The U.S. consumer sentiment takes a hit in early October from the rising concerns over surging coronavirus cases and inflationary levels.
Momentum ETFs Looking Attractive Amid Latest Market Optimism
Wall Street is expected to continue gaining on optimism surrounding new economic data and third-quarter earnings releases, which point to recovery from the pandemic-induced slowdown.
United States Oil Fund (USO) Hits a 52-Week High
The United States Oil Fund (USO) hits a new 52-week high. Are more gains in store?
4 ETF Areas for Investors to Make the Most of Q4
Let’s take a look at some ETF areas that are looking decent investment options for the investors to park their money in Q4.
Ride the Latest Market Rally With These ETFs
The third-quarter earnings season has begun with a bang, spreading optimism among investors.
5 Dividend Aristocrat ETFs in Focus for a Stable Finish to Q4
Dividend aristocrats are likely to perform well and are attractive investment options for an impressive finish to 2021.